The importance of prenatal diagnosis and examination in the perinatal care of fetuses and newborns with sacrococcygeal teratomas

Authors

  • O.K. Sliepov Center for neonatal surgery for malformations and their rehabilitation of SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0000-0002-6976-1209
  • O.V. Perederii Center for neonatal surgery for malformations and their rehabilitation of SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0009-0001-7531-8537
  • G.O. Grebinichenko SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0000-0003-4391-6724
  • N.Y. Skrypchenko SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0000-0003-2849-8499

DOI:

https://doi.org/10.15574/PP.2024.98.60

Keywords:

sacrococcygeal teratoma, prenatal diagnosis, perinatal support, examination of the fetus, newborn child

Abstract

Aim: to determine the importance of prenatal diagnosis in the perinatal care of fetuses and newborns with sacrococcygeal teratomas

Materials and methods. A retrospective analysis of the medical cards of 26 newborns with sacrococcygeal teratomas (SCT) who underwent surgery in the period from 1983 to 2023. A statistical analysis of the value of prenatal diagnosis criteria in the perinatal care of fetuses and newborns with SCT was perfomed. P values less than 0.05 were considered reliable.

Results. Prenatal SCT was diagnosed in 69.2% (n=18) of fetuses. The criteria for prenatal diagnosis and its importance in the perinatal support of fetuses and newborns with SCT were determined. Tumor volume growth >100 cm3/week (p=0.0189), tumor-corporal index - TFR>0.12 (p=0.0007), tumor-cranial index - TV:HV >1 (p=0.0006) had a reliable influence on the pathological process, tactics of pregnancy and childbirth.

Conclusions. Prenatal diagnosis and dispensation make it possible to detect fetal SCT in advance, to detail its features and to observe the dynamics of the pathological process during different periods of gestation. The developed method of determining the dynamics of fetal tumor growth, as well as the use of the proposed TFR and TV:HV indices, are reliable risk factors that affect the intrauterine passing of the pathological process, the frequency of dispensary monitoring, the tactics of pregnancy management, the terms of hospitalization in the clinic and the delivery of the pregnant woman. The developed classification of tumor growth rate in the fetus within 1 week has important practical significance in predicting the antenatal passing of the pathological process.

The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of all institutions mentioned in the work. Informed consent of the women was obtained for the research.

The authors declare no conflict of interest.

References

Akinkuotu AC, Coleman A, Shue E, Sheikh F, Hirose S et al. (2015, May). Predictors of poor prognosis in prenatally diagnosed sacrococcygeal teratoma: A multiinstitutional review. J Pediatr Surg. 50(5): 771-774. https://doi.org/10.1016/j.jpedsurg.2015.02.034; PMid:25783370

Altman RP, Randolph JG, Lilly JR. (1974). Sacrococcygeal teratoma: American Academy of Pediatrics Survey. J Pediatr Surg. 9 (3): 389-398. https://doi.org/10.1016/S0022-3468(74)80297-6; PMid:4843993

Ballantyne JW. (1874). Teratologie. Williams and Nougate.

Bardi F, Bergman JEH, Siemensma-Mühlenberg N, Elvan-Taşpınar A, de Walle HEK, Bakker MK. (2022). Prenatal diagnosis and pregnancy outcome of major structural anomalies detectable in the first trimester: A population-based cohort study in the Netherlands. Paediatr Perinat Epidemiol. 36(6): 804-814. https://doi.org/10.1111/ppe.12914; PMid:35821640 PMCid:PMC9796468

Buijtendijk M, Shah H, Lugthart MA, Dawood Y, Limpens J, Bakker BS et al. (2021, Jul 21). Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low‐risk and unselected populations. Cochrane Database Syst Rev. 2021(7): CD014715. https://doi.org/10.1002/14651858.CD014715; PMCid:PMC8406822

Coleman A, Kline-Fath B, Keswani S et al. (2013). Prenatal solid tumor volume index: novel prenatal predictor of adverse outcome in sacrococcygeal teratoma. J Surg Res. 184: 330-336. https://doi.org/10.1016/j.jss.2013.05.029; PMid:23773720

Gucciardo L, Uyttebroek A, De Wever I, Renard M, Claus F, Devlieger R et al. (2011, Jul). Prenatal assessment and management of sacrococcygeal teratoma. Prenat Diagn. 31(7): 678-688. https://doi.org/10.1002/pd.2781; PMid:21656530

Hambraeus M, Arnbjörnsson E, Börjesson A, Salvesen K, Hagander L. (2016, Mar). Sacrococcygeal teratoma: A population-based study of incidence and prenatal prognostic factors. J Pediatr Surg. 51(3): 481-485. https://doi.org/10.1016/j.jpedsurg.2015.09.007; PMid:26454470

Kozlowski P, Burkhardt T, Gembruch U et al. (2019). DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures. Empfehlungen der DEGUM, der ÖGUM, der SGUM und der FMF Deutschland zum Einsatz von Ersttrimester-Screening, früher Fehlbildungsdiagnostik, Screening an zellfreier DNA (NIPT) und diagnostischen Punktionen. Ultraschall Med. 40(2): 176-193. https://doi.org/10.1055/a-0631-8898; PMid:30001568

Kremer MEB, Althof JF, Derikx JPM et al. (2018). The incidence of associated abnormalities in patients with sacrococcygeal teratoma. J Pediatr Surg. 53(10): 1918-1922. https://doi.org/10.1016/j.jpedsurg.2018.01.013; PMid:29453131

Mahmoud, Mohamed H. et al. (2023). Antenatal Diagnosis Of Sacrococcygeal Teratoma, The Combined Use Of Fetal MRI And Ultrasound In Diagnosis. Case Series. Journal of Pharmaceutical Negative Results, 14; 2: 2763-2767.

Makin EC, Hyett J, Ade-Ajayi N et al. (2006). Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993-2004). J Pediatr Surg. 41 (2): 388-393. https://doi.org/10.1016/j.jpedsurg.2005.11.017; PMid:16481257

Markov D, Chernev T, Dimitrova V, Mazneĭkova V, Leroy Y, Jacquemyn Y et al. (2004). Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks. Akush Ginekol (Sofiia). 43(3): 3-10.

Masahata K, Ichikawa C, Makino K, Abe T, Kim K, Yamamichi T et al. (2020). Long-term functional outcome of sacrococcygeal teratoma after resection in neonates and infants: a single-center experience. Pediatr Surg Int. 36: 1327-1332. https://doi.org/10.1007/s00383-020-04752-7; PMid:32990839

Mistri PK, Patua B, Alam H, Ray S, Bhattacharyya SK. (2012). Large sacrococcygeal teratoma hindering vaginal delivery attempted at home. Rev Obstet Gynecol. 5(2): 65-68.

Mourad AP, De Robles MS, O'Toole S, Paver E, Winn RD. (2020, Nov 28). A case of an asymptomatic sacrococcygeal teratoma diagnosed in adulthood. J Surg Case Rep. 2020(11). https://doi.org/10.1093/jscr/rjaa462; PMid:33294159 PMCid:PMC7700776

Özsürmeli M, Büyükkurt S, Sucu M, Arslan E, Mısırlıoğlu S, Akçabay Ç et al. (2020, Sep). Evaluation of prenatally diagnosed fetal sacrococcygeal teratomas: A case series of seventeen pregnancies from South-central Turkey. Turk J Obstet Gynecol. 17(3): 170-174. https://doi.org/10.4274/tjod.galenos.2020.68812; PMid:33072420 PMCid:PMC7538821

Phi JH. (2021, May). Sacrococcygeal Teratoma: A Tumor at the Center of Embryogenesis. J Korean Neurosurg Soc. 64(3): 406-413. https://doi.org/10.3340/jkns.2021.0015; PMid:33906346 PMCid:PMC8128526

Rattan KN, Singh J. (2021, Apr). Neonatal sacrococcygeal teratoma: Our 20-year experience from a tertiary care centre in North India. Trop Doct. 51(2): 209-212. https://doi.org/10.1177/0049475520973616; PMid:33356941

Roybal JL, Moldenhauer JS, Khalek N, Bebbington MW, Johnson MP, Hedrick HL et al. (2011, Jul). Early delivery as an alternative management strategy for selected high-risk fetal sacrococcygeal teratomas. J Pediatr Surg. 46(7): 1325-1232. https://doi.org/10.1016/j.jpedsurg.2010.10.020; PMid:21763829

Salomon LJ, Alfirevic Z, Berghella V et al. (2022). ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan [published correction appears in Ultrasound Obstet Gynecol. 2022 Oct; 60(4): 591]. Ultrasound Obstet Gynecol. 59(6): 840-856. https://doi.org/10.1002/uog.24888; PMid:35592929

Shue E, Bolouri M, Jelin EB, Vu L, Bratton B, Cedars E et al. (2013). Tumor metrics and morphology predict poor prognosis in prenatally diagnosed sacrococcygeal teratoma: a 25-year experience at a single institution. J Pediatr Surg. 48: 1225-1231. https://doi.org/10.1016/j.jpedsurg.2013.03.016; PMid:23845611

Van Mieghem T, Al-Ibrahim A, Deprest J, Lewi L, Langer JC, Baud D et al. (2014б Jun). Minimally invasive therapy for fetal sacrococcygeal teratoma: case series and systematic review of the literature. Ultrasound Obstet Gynecol. 43(6): 611-619. https://doi.org/10.1002/uog.13315; PMid:24488859

Vedmedovska N, Bokucava D, Lisovaja I. (2022), EP24.19: Fetal sacral teratoma from the first trimester to birth: differential diagnosis, prognosis and outcome. Ultrasound Obstet Gynecol. 60: 194-195. https://doi.org/10.1002/uog.25589

Virchow R. (1863). Die Krankhafte Geschwülste. I. Hirschwald; Berlin: 96.

Wakhlu A, Misra S, Tandon RK, Wakhlu AK. (2002, Sep). Sacrococcygeal teratoma. Pediatr Surg Int. 18(5-6): 384-387. https://doi.org/10.1007/s00383-002-0729-z; PMid:12415361

Weerakkody Y, Yap J, Iqbal S et al. (2023). Sacrococcygeal teratoma. Reference article, Radiopaedia.org (Accessed on 23 Oct 2023). URL: https://radiopaedia.org/articles/sacrococcygeal-teratoma. https://doi.org/10.53347/rld-8307.

Willis RA. (1951).Teratomas, Atlas of Tumor Pathology, first series. Armed Forces Institute of Pathology; Washington.

Zvizdic Z et al. (2023, Mar). A Long-Term Outcome of the Patients with Sacrococcygeal Teratoma: A Bosnian Cohort. Turk Arch Pediatr. 58(2): 168-173. https://doi.org/10.5152/TurkArchPediatr.2023.22268; PMid:36856354 PMCid:PMC10081131

Published

2024-06-28